Celgene
Showing 51 - 75 of 1,034
Non Hodgkin's Lymphoma Trial in Sacramento, Santa Rosa (Rituximab, Lenalidomide)
Active, not recruiting
- Non Hodgkin's Lymphoma
-
Sacramento, California
- +1 more
Nov 15, 2021
Mantle Cell Lymphoma Trial in New York (Acalabrutinib, Lenalidomide, Rituximab)
Recruiting
- Mantle Cell Lymphoma
- Acalabrutinib
- +2 more
-
New York, New YorkWeill Cornell Medicine
Oct 29, 2021
Partial Response of Multiple Myeloma or Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Buffalo, Rochester (biological,
Active, not recruiting
- Partial Response of Multiple Myeloma or Plasma Cell Leukemia
- Plasma Cell Myeloma
- Incomplete Freund's Adjuvant
- +4 more
-
Buffalo, New York
- +1 more
Dec 12, 2022
Relapsed/Refractory Multiple Myeloma Trial in La Jolla (Ixazomib, Pomalidomide, Dexamethasone)
Recruiting
- Relapsed/Refractory Multiple Myeloma
- Ixazomib
- +3 more
-
La Jolla, CaliforniaUCSD Moores Cancer Center
Mar 7, 2022
Treatment Outcomes of Esophageal Cancer
Recruiting
- Esophageal Cancer
- Assessment of patient-reported outcomes (PROs)
-
Bomet, Kenya
- +5 more
Dec 15, 2021
CNS Tumor, Cranial Nerve Disorder, Metastatic Malignant Tumor in the Brain Trial in Portland (Ferumoxytol, Gadolinium, Magnetic
Recruiting
- Central Nervous System Neoplasm
- +2 more
- Ferumoxytol
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Jun 2, 2022
Cord Compression Trial in Saint Louis (Radiation therapy, nab-Paclitaxel)
Terminated
- Cord Compression
- Radiation therapy
- nab-Paclitaxel
-
Saint Louis, MissouriWashington University School of Medicine
Oct 15, 2021
Demyelinating Sensorimotor Neuropathy Trial in Ann Arbor, Columbus (Lenalidomide)
Active, not recruiting
- Demyelinating Sensorimotor Neuropathy
-
Ann Arbor, Michigan
- +1 more
Nov 3, 2021
Acute Myelogenous Leukemia Trial in Atlanta, Boston, Madison (DC/AML Fusion Vaccine, Observation)
Recruiting
- Acute Myelogenous Leukemia
- DC/AML Fusion Vaccine
- Observation
-
Atlanta, Georgia
- +4 more
Apr 14, 2022
Nummular Eczema, Eczema, Dermatitis Eczema Trial in Munich (Apremilast, Placebo Oral Tablet)
Completed
- Nummular Eczema
- +3 more
- Apremilast
- Placebo Oral Tablet
-
Munich, Bavaria, GermanyTechnical University Munich - Department of Dermatology
Oct 7, 2021
Metastatic NSCLC (NSCLC), NSCLC Metastatic, NSCLC Stage II Trial in Oldenburg (data collection)
Recruiting
- Metastatic Non-small Cell Lung Cancer (NSCLC)
- +5 more
- data collection
-
Oldenburg, GermanyPius-Hospital
Jul 20, 2022
Multiple Myeloma Trial in Tampa (Lenalidomide, Prednisone, Dexamethasone)
Completed
- Multiple Myeloma
- Lenalidomide
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Oct 8, 2021
Acute Myeloid Leukemia Trial in Chapel Hill (Lenalidomide)
Completed
- Acute Myeloid Leukemia
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill - Lineberger Compreh
Jan 25, 2022
Itch Trial in Saint Louis (Apremilast)
Completed
- Itch
-
Saint Louis, MissouriWashington University Division of Dermatology
Jun 23, 2021
Prostate Cancer, Castration Resistant Prostate Cancer Trial in United States (Enzalutamide, CC-115)
Active, not recruiting
- Prostate Cancer
- Castration Resistant Prostate Cancer
-
San Francisco, California
- +4 more
Mar 18, 2022
APRemilast in Moderate psoriAsIS in Real Life clinicAL Practice
Completed
- Moderate Plaque Psoriasis
-
Athens, Greece401 General Military Hospital
Aug 16, 2021
Multiple Myeloma, Non-Hodgkin's Lymphoma Trial in United States (Romidepsin, Lenalidomide)
Active, not recruiting
- Multiple Myeloma
- Non-Hodgkin's Lymphoma
-
Hartford, Connecticut
- +6 more
Jan 3, 2023
Pancreatic Cancer, Pancreatic Adenocarcinoma, Pancreas Ductal Adenocarcinoma Trial in United States (Nab-paclitaxel and
Active, not recruiting
- Pancreatic Cancer
- +2 more
- Nab-paclitaxel and gemcitabine for R-PDAC Patients
- Nab-paclitaxel and gemcitabine for BR-PDAC Patients
-
Scottsdale, Arizona
- +3 more
Mar 8, 2022
Chronic Lymphocytic Leukemia, CLL Trial in La Jolla (Revlimid, Rituximab)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- CLL
-
La Jolla, CaliforniaUniversity of California, San Diego
Sep 2, 2021
Multiple Myeloma Trial in Baltimore (biological, drug, other)
Recruiting
- Multiple Myeloma
- GM-CSF vaccine
- +4 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 6, 2022
Cutaneous T-cell Lymphoma, T-Prolymphocytic Leukemia, T-Large Granulocytic Leukemia Trial in Columbus (Romidepsin, Busulfan,
Recruiting
- Cutaneous T-cell Lymphoma
- +4 more
- Romidepsin
- +4 more
-
Columbus, OhioThe Ohio State University Cancer Center
Apr 18, 2022